Scott A. Kelly - 30 Jun 2022 Form 4 Insider Report for CytoDyn Inc. (CYDY)

Role
CMO, Director
Signature
/s/ Antonio Migliarese, Attorney-In-Fact
Issuer symbol
CYDY
Transactions as of
30 Jun 2022
Net transactions value
$0
Form type
4
Filing time
05 Jul 2022, 17:14:55 UTC
Previous filing
21 Jun 2022
Next filing
19 Jul 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CYDY Common Stock Award $0 +13,736 +0.67% $0.000000 2,053,207 30 Jun 2022 Direct F1
holding CYDY Common Stock 782,408 30 Jun 2022 By Spouse
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents awards of fully vested shares under the issuer's 2012 Equity Incentive Plan approved by its Compensation Committee of the Board of Directors with a value on the respective date of grant equal to reduction in reporting person's cash salary.

Remarks:

EX 24 - Power of Attorney